A comprehensive view of respiratory / lung health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
BRISTOL MYERS SQUIBB CO - 10-Q - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Published:
April 25, 2024
by SEC Edgar Filings
|
Moderna To present respiratory & cytomegalovirus research at the ESCMID Global Congress
Published:
April 25, 2024
by Moderna Inc.
|
US Patent Issued to Pfizer on April 23 for "Heteroaromatic compounds and their use as dopamine D1 ligands" (Massachusetts, Connecticut, Colorado Inventors)
Published:
April 24, 2024
by U.S. Fed News
|
U.S. Patent and Trademark Office Releases Pfizer Inc's Patent Application for Pyrido[2,3-D]Imidazole Derivatives and Their Use as Inhibitors of ITK for the Treatment of Skin Disease
Published:
April 22, 2024
by Pharmaceutical Patent News
|
Eli Lilly and Company Submits Patent Application for FGFR3 Inhibitor Compounds
Published:
April 20, 2024
by Pharmaceutical Patent News
|
Ask us about our Health Care Sector market view